BSCX yields 4.91% · JNJ yields 3.36%● Live data
📍 BSCX pulled ahead of the other in Year 1
Combined, BSCX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BSCX + JNJ for your $10,000?
The Invesco BulletShares 2033 Corporate Bond ETF (Fund) is based on the BulletShares USD Corporate Bond 2033 Index (Index). The Fund will invest at least 80% of its total assets in corporate bonds that comprise the index. The Index seeks to measure the performance of a portfolio of US dollar-denominated, investment-grade corporate bonds with effective maturities in 2033. The Fund does not purchase all of the securities in the Index; instead, the Fund utilizes a "sampling" methodology to seek to achieve its investment objective. The Fund and the Index are rebalanced monthly. The Fund has a designated year of maturity of 2033 and will terminate on or about Dec. 15, 2033. See the prospectus for more information.
Full BSCX Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.